Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

The role of oncogenic viruses in the pathogenesis of hepatocellular carcinoma.

Zemel R, Issachar A, Tur-Kaspa R.

Clin Liver Dis. 2011 May;15(2):261-79, vii-x. doi: 10.1016/j.cld.2011.03.001. Review.

PMID:
21689612
2.

Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.

Tamori A, Nishiguchi S, Shiomi S, Hayashi T, Kobayashi S, Habu D, Takeda T, Seki S, Hirohashi K, Tanaka H, Kubo S.

Am J Gastroenterol. 2005 Aug;100(8):1748-53.

PMID:
16086711
3.

Oncogenic viruses and hepatocellular carcinoma.

Ben Ari Z, Weitzman E, Safran M.

Clin Liver Dis. 2015 May;19(2):341-60. doi: 10.1016/j.cld.2015.01.006. Epub 2015 Mar 7. Review.

PMID:
25921667
4.

Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma.

De Mitri MS, Cassini R, Morsica G, Bagaglio S, Andreone P, Loggi E, Muratori P, Bernardi M.

J Viral Hepat. 2006 Sep;13(9):574-81.

PMID:
16907843
5.

Coexpression network analysis in chronic hepatitis B and C hepatic lesions reveals distinct patterns of disease progression to hepatocellular carcinoma.

He D, Liu ZP, Honda M, Kaneko S, Chen L.

J Mol Cell Biol. 2012 Jun;4(3):140-52. doi: 10.1093/jmcb/mjs011. Epub 2012 Mar 31.

PMID:
22467683
6.

Hepatitis B and C virus-related carcinogenesis.

Fung J, Lai CL, Yuen MF.

Clin Microbiol Infect. 2009 Nov;15(11):964-70. doi: 10.1111/j.1469-0691.2009.03035.x. Review.

7.
8.

Treatment of chronic hepatitis C in Asia: when East meets West.

Yu ML, Chuang WL.

J Gastroenterol Hepatol. 2009 Mar;24(3):336-45. doi: 10.1111/j.1440-1746.2009.05789.x. Review.

PMID:
19335784
9.

Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.

Zondervan PE, Wink J, Alers JC, IJzermans JN, Schalm SW, de Man RA, van Dekken H.

J Pathol. 2000 Oct;192(2):207-15.

PMID:
11004697
10.

Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinoma.

Lin CI, Lin ZY, Hsieh MY, Huang CF, Chen SH, Chuang WL.

Kaohsiung J Med Sci. 2011 Dec;27(12):554-9. doi: 10.1016/j.kjms.2011.06.029. Epub 2011 Nov 25.

11.

Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.

Yin J, Zhang H, Li C, Gao C, He Y, Zhai Y, Zhang P, Xu L, Tan X, Chen J, Cheng S, Schaefer S, Cao G.

Carcinogenesis. 2008 Sep;29(9):1685-91. doi: 10.1093/carcin/bgm301. Epub 2008 Jan 12.

PMID:
18192693
12.

Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?

Lok AS.

J Gastroenterol Hepatol. 2011 Feb;26(2):221-7. doi: 10.1111/j.1440-1746.2010.06576.x.

PMID:
21070361
13.

[Clinical examinations based on nucleic acids of hepatitis viruses].

Tanaka Y, Mizokami M.

Rinsho Byori. 2006 Nov;54(11):1164-71. Review. Japanese.

PMID:
17240839
14.

The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.

Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.

J Exp Clin Cancer Res. 1999 Sep;18(3):379-89. Erratum in: J Exp Clin Cancer Res 2000 Mar;19(1):125.

PMID:
10606185
15.

Hepatocellular carcinoma in Sweden: its association with viral hepatitis, especially with hepatitis C viral genotypes.

Widell A, Verbaan H, Wejstål R, Kaczynski J, Kidd-Ljunggren K, Wallerstedt S.

Scand J Infect Dis. 2000;32(2):147-52.

PMID:
10826899
16.

Viral hepatitis and liver cancer: the case of hepatitis C.

Levrero M.

Oncogene. 2006 Jun 26;25(27):3834-47. Review.

PMID:
16799625
17.

Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.

Mahmood S, Niiyama G, Kamei A, Izumi A, Nakata K, Ikeda H, Suehiro M, Kawanaka M, Togawa K, Yamada G.

Liver Int. 2005 Apr;25(2):220-5.

PMID:
15780042
18.
19.

Angiogenic activity of hepatitis B and C viruses.

Vrancken K, Paeshuyse J, Liekens S.

Antivir Chem Chemother. 2012 Jan 17;22(4):159-70. doi: 10.3851/IMP1987. Review.

PMID:
22182803
20.

Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?

Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaira T, Payawal DA, Ono-Nita SK, Imamura M, Kato N, Omata M.

Cancer. 1997 Dec 1;80(11):2060-7.

PMID:
9392327

Supplemental Content

Support Center